NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,856,633 | +224.9% | 616,890 | +329.7% | 0.00% | +100.0% |
| Q2 2023 | $3,648,974 | -44.5% | 143,547 | -21.0% | 0.00% | 0.0% |
| Q1 2023 | $6,569,661 | -46.9% | 181,733 | -41.8% | 0.00% | -66.7% |
| Q4 2022 | $12,366,026 | +192.1% | 312,273 | +243.7% | 0.00% | +200.0% |
| Q3 2022 | $4,234,000 | +12.9% | 90,855 | +6.2% | 0.00% | 0.0% |
| Q2 2022 | $3,750,000 | -45.0% | 85,549 | -9.2% | 0.00% | 0.0% |
| Q1 2022 | $6,818,000 | -9.3% | 94,259 | +1.6% | 0.00% | 0.0% |
| Q4 2021 | $7,520,000 | +88.8% | 92,769 | +171.1% | 0.00% | 0.0% |
| Q3 2021 | $3,982,000 | -78.8% | 34,218 | -69.8% | 0.00% | -75.0% |
| Q2 2021 | $18,812,000 | -61.2% | 113,465 | -67.3% | 0.00% | -66.7% |
| Q1 2021 | $48,461,000 | +2.7% | 347,388 | +27.4% | 0.01% | 0.0% |
| Q4 2020 | $47,188,000 | +9.6% | 272,603 | -11.8% | 0.01% | 0.0% |
| Q3 2020 | $43,039,000 | +16.2% | 308,965 | -0.3% | 0.01% | +9.1% |
| Q2 2020 | $37,035,000 | +97.5% | 309,996 | +65.3% | 0.01% | +57.1% |
| Q1 2020 | $18,752,000 | -39.0% | 187,558 | -28.2% | 0.01% | -12.5% |
| Q4 2019 | $30,722,000 | +50.3% | 261,374 | +10.0% | 0.01% | +33.3% |
| Q3 2019 | $20,434,000 | +370.9% | 237,689 | +255.1% | 0.01% | +500.0% |
| Q2 2019 | $4,339,000 | -47.9% | 66,929 | -49.8% | 0.00% | -66.7% |
| Q1 2019 | $8,334,000 | +186.4% | 133,325 | +78.2% | 0.00% | +200.0% |
| Q4 2018 | $2,910,000 | -42.1% | 74,826 | -15.1% | 0.00% | 0.0% |
| Q3 2018 | $5,023,000 | -91.6% | 88,129 | -88.2% | 0.00% | -93.8% |
| Q2 2018 | $59,868,000 | -24.4% | 749,756 | -18.0% | 0.02% | -20.0% |
| Q1 2018 | $79,231,000 | +19.0% | 914,171 | -5.2% | 0.02% | +25.0% |
| Q4 2017 | $66,580,000 | -39.2% | 964,356 | -19.9% | 0.02% | -40.7% |
| Q3 2017 | $109,428,000 | +27.9% | 1,204,093 | +4.8% | 0.03% | +22.7% |
| Q2 2017 | $85,525,000 | -38.6% | 1,149,064 | -22.7% | 0.02% | -42.1% |
| Q1 2017 | $139,257,000 | +35.7% | 1,486,197 | +5.2% | 0.04% | +31.0% |
| Q4 2016 | $102,639,000 | +23.4% | 1,412,582 | +77.2% | 0.03% | +16.0% |
| Q3 2016 | $83,202,000 | +535.2% | 797,032 | +348.8% | 0.02% | +525.0% |
| Q2 2016 | $13,099,000 | -63.1% | 177,599 | -71.9% | 0.00% | -66.7% |
| Q1 2016 | $35,531,000 | +149.4% | 631,568 | +199.2% | 0.01% | +200.0% |
| Q4 2015 | $14,249,000 | -5.4% | 211,067 | -35.0% | 0.00% | -20.0% |
| Q3 2015 | $15,061,000 | +236.5% | 324,673 | +289.9% | 0.01% | +150.0% |
| Q2 2015 | $4,476,000 | +1119.6% | 83,270 | +776.4% | 0.00% | – |
| Q4 2014 | $367,000 | – | 9,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |